Additional Courses of Alemtuzumab Improved Clinical and MRI Outcomes in Pooled CARE-MS I and II Patients With Disease Activity After Two Courses: Analysis of Patients Who Received >= 3 Courses

著录项

• 来源
  《Multiple sclerosis: clinical and laboratory research》 |2019年第3期|共2页
• 作者

  Kim H. J.; Traboulsee A.; Bass A. D.; Boster A.; Berkovich R.; Comi G.; Fernandez O.; Limmroth V.; Lycke J.; Macdonell R. A. L.; Schippling S.; Vermersch P.; Wiendl H.; Ziemssen T.; Chung L.; Daizadeh N.; Rodriguez C. E.; Singer B. A.;

  展开▼
• 作者单位

  Natl Canc Ctr Res Inst &

  Hosp Goyang South Korea;

  Univ British Columbia Vancouver BC Canada;

  Neurol Ctr San Antonio San Antonio TX USA;

  OhioHlth Neurol Phys Columbus OH USA;

  Univ Southern Calif Keck Sch Med Los Angeles CA USA;

  Univ Vita Salute San Raffaele Milan Italy;

  Hosp Univ Carlos Haya Fdn IMABIS Malaga Spain;

  Klin Neurol &

  Palliat Med Cologne Germany;

  Univ Gothenburg Gothenburg Sweden;

  Austin Hlth Melbourne Vic Australia;

  Univ Hosp Zurich Neuroimmunol &

  Multiple Sclerosis Res Zurich Switzerland;

  Univ Lille Lille France;

  Univ Munster Munster Germany;

  Carl Gustav Carus Univ Hosp Ctr Clin Neurosci Dresden Germany;

  Sanofi Cambridge MA USA;

  Sanofi Cambridge MA USA;

  Sanofi Cambridge MA USA;

  Missouri Baptist Med Ctr MS Ctr Innovat Care St Louis MO USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 神经病学与精神病学;
• 关键词